Tetratherix Limited

Tetratherix has developed a biostealth fluid matrix that evolves regenerative medicine. The company's mission is to use the Tetramatrix™ platform technology to help treat 10 million patients by 2035 by developing therapies, solutions and products that enable the future of healthcare delivery.